SUBSTITUIERTE IMIDAZOCHINOLINE

European patent · EP3679038 · In force

Register entry

Publication number
EP3679038
Application number
EP18759137
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 31, 2018
Published
Jul 15, 2020
Granted
Apr 3, 2024
Protection ends at the latest
Aug 30, 2038
Next annual fee due
Aug 31, 2027
IPC classes
C07D 471/04 (2006.01)
A61K 31/4745 (2006.01)
A61P 35/00 (2006.01)
Priority
WO PCT/EP2017/072352 06.09.2017
PCT application
PCT/EP2018/073470 31.08.2018
PCT publication
WO2019/048350 14.03.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Feb 12, 2025

    Change

    Published in Swissreg on 12.02.2025

  4. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  5. Apr 26, 2024

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 26.04.2024

  6. Apr 3, 2024

    Granted

    Published in Swissreg on 03.04.2024

Parties

Holder

BioNTech SE

Biontech SE

An der Goldgrube 12, 55131 Mainz, DE

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

HENRY, Christophe

81479 Munich, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.